Income Taxes (Details) - Schedule of deferred tax assets and liabilities - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Deferred tax assets:
Net operating loss carry forwards	$ 26,768	$ 23,350
Capitalized research and development	3,418
Stock option expense	2,477	920
Research and development credits	3,710	1,551
Operating lease liability	1,481	1,564
RSU expense	2,199	1,960
Other	408	7
Total deferred tax assets	40,461	29,352
Valuation allowance	(38,983)	(27,803)
Deferred tax assets, net of valuation allowance	1,478	1,549
Deferred tax liabilities:
Operating right-of-use asset	(1,456)	(1,549)
Other	(22)
Total deferred tax liabilities	(1,478)	(1,549)
Deferred tax assets, net of valuation allowance and deferred tax liabilities